Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis

被引：58
|
作者：
Schwartz, Noa
Michaelson, Jennifer S.
Putterman, Chaim
机构：
[1] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10461 USA
[2] Biogen Idec Inc, Cambridge, MA USA
来源：
AUTOIMMUNITY, PART A: BASIC PRINCIPLES AND NEW DIAGNOSTIC TOOLS | 2007年 / 1109卷
关键词：
systemic lupus erythematosus; lupus nephritis; biomarkers; TWEAK; Lipocalin-2;
D O I：
10.1196/annals.1398.032
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Lupus nephritis (LN) is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). As the course of LN is often unpredictable, it is important to identify reliable, noninvasive methods to repeatedly assess the condition of the kidneys in these patients. Urinary biomarkers are easily obtained and probably are best at reflecting the current renal status, as they specifically represent local inflammatory activity. In this article, we review a number of potential urinary biomarkers, including Lipocalin-2, MCP-1, IP-10, IL-6, and IL-8. Additionally, we provide evidence for the possible utility of the novel cytokine TWEAK as a urinary biomarker for LN.
引用
收藏
页码：265 / 274
页数：10
相关论文
共 50 条
  • [1] Association of Urinary Lipocalin-2 with Lupus Nephritis
    Sharifipour, Farzaneh
    Zeraati, Abbasali
    Sahebari, Maryam
    Hatef, Mohammadreza
    Naghibi, Masih
    Rezaieyazdi, Zahra
    Mahmoudi, Mahmoud
    Azarian, Amir Abbas
    Mirfeizi, Zahra
    Samadi, Katayoun
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2013, 16 (09) : 1011 - 1015
  • [2] Urinary lipocalin-2 is upregulated in murine and human lupus nephritis
    Pitashny, Milena
    CLINICAL IMMUNOLOGY, 2007, 123 : S83 - S83
  • [3] Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis
    Pitashny, Milena
    Schwartz, Noa
    Qing, Xiaoping
    Hojaili, Bernard
    Aranow, Cynthia
    Mackay, Meggan
    Putterman, Chaim
    ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1894 - 1903
  • [4] Lipocalin-2 as a Marker of Severe Lupus Nephritis in Children
    Hammad, A.
    Mosaad, Y.
    El-Hanbly, S.
    Youssef, H.
    El-Refaey, A.
    El-Husseini, F.
    Bakr, A.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1803 - 1804
  • [5] URINARY LIPOCALIN-2 AS A BIOMARKER OF RENAL DISEASE ACTIVITY IN PATIENTS WITH LUPUS NEPHRITIS: A PROSPECTIVE STUDY
    Gamal, N. M.
    Mustafa, N. M.
    Abda, E. A. M.
    Afifi, O.
    Fathi, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 808 - 809
  • [6] URINARY LEVELS OF VCAM-1 AND TWEAK AS BIOMARKERS OF LUPUS NEPHRITIS
    Urrego, T.
    Ortiz-Reyes, B.
    Aroca, G.
    Vanegas-Garcia, A. L.
    Cadena Bonfanti, A. A.
    Almendrales, L.
    Munoz, C. H.
    Gonzalez, L. A.
    Iglesias, A.
    Vasquez, G.
    Gomez-Puerta, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1239 - 1239
  • [7] Urinary TWEAK and the activity of lupus nephritis
    Schwartz, Noa
    Su, Lihe
    Burkly, Linda C.
    Mackay, Meggan
    Aranow, Cynthia
    Kollaros, Maria
    Michaelson, Jennifer S.
    Rovin, Brad
    Putterman, Chaim
    JOURNAL OF AUTOIMMUNITY, 2006, 27 (04) : 242 - 250
  • [8] EVALUATION OF TWEAK AND MCP-1 AS URINARY BIOMARKERS FOR THE EVALUATION OF LUPUS NEPHRITIS ACTIVITY
    Casablanca Alarcon, Esther
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S38 - S38
  • [9] Urinary cytokines and mRNA expression as biomarkers of disease activity in lupus nephritis
    Jakiela, B.
    Kosalka, J.
    Plutecka, H.
    Wegrzyn, A. S.
    Bazan-Socha, S.
    Sanak, M.
    Musial, J.
    LUPUS, 2018, 27 (08) : 1259 - 1270
  • [10] CYTOKINES AND LIPOCALIN-2 IN PREGNANT WOMEN WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Pedersen, T. T.
    Fenstad, M. H.
    Moksnes, T. S.
    Wallenius, M.
    Flo, T. H.
    Haug, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 223 - 223
12345